28/120
1.2 / 5 stars
All 120 Win/Lose results shown below
CPIX Roast Me summary
CUMBERLAND PHARMACEUTICALS INC (CPIX). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinCPIX / S&P 99.38% / 15.20% |
LoseCPIX / S&P -5.15% / 15.00% |
LoseCPIX / S&P CPIX unavailable / 50.40% |
| 2026-Q10/3 |
LoseCPIX / S&P -18.34% / -4.33% |
LoseCPIX / S&P 2.08% / 11.30% |
LoseCPIX / S&P CPIX unavailable / 27.70% |
| 2025-Q42/3 |
WinCPIX / S&P 27.56% / 2.65% |
WinCPIX / S&P 17.57% / 9.00% |
LoseCPIX / S&P CPIX unavailable / 13.40% |
| 2025-Q31/3 |
LoseCPIX / S&P -6.87% / 8.12% |
WinCPIX / S&P 12.21% / 4.61% |
LoseCPIX / S&P CPIX unavailable / 13.45% |
| 2025-Q21/3 |
LoseCPIX / S&P -20.80% / 10.94% |
WinCPIX / S&P 11.34% / 4.83% |
LoseCPIX / S&P CPIX unavailable / 10.63% |
| 2025-Q12/3 |
WinCPIX / S&P 78.48% / -4.27% |
WinCPIX / S&P 5.82% / 4.98% |
LoseCPIX / S&P CPIX unavailable / 10.57% |
| 2024-Q41/3 |
WinCPIX / S&P 85.16% / 2.41% |
LoseCPIX / S&P -4.26% / 5.25% |
LoseCPIX / S&P CPIX unavailable / 6.15% |
| 2024-Q30/3 |
LoseCPIX / S&P -16.34% / 5.89% |
LoseCPIX / S&P -6.45% / 5.89% |
LoseCPIX / S&P CPIX unavailable / 6.11% |
| 2024-Q20/3 |
LoseCPIX / S&P -8.93% / 4.28% |
LoseCPIX / S&P -7.05% / 5.38% |
LoseCPIX / S&P CPIX unavailable / 5.12% |
| 2024-Q10/3 |
LoseCPIX / S&P -6.15% / 10.56% |
LoseCPIX / S&P -3.08% / 5.71% |
LoseCPIX / S&P CPIX unavailable / 5.59% |
| 2023-Q40/3 |
LoseCPIX / S&P -5.29% / 11.69% |
LoseCPIX / S&P -5.85% / 6.81% |
LoseCPIX / S&P CPIX unavailable / 7.78% |
| 2023-Q31/3 |
WinCPIX / S&P 28.57% / -3.27% |
LoseCPIX / S&P -2.34% / 7.52% |
LoseCPIX / S&P CPIX unavailable / -5.03% |
| 2023-Q21/3 |
LoseCPIX / S&P -24.62% / 8.74% |
WinCPIX / S&P 10.08% / 9.50% |
LoseCPIX / S&P CPIX unavailable / -8.57% |
| 2023-Q11/3 |
LoseCPIX / S&P -13.33% / 7.50% |
WinCPIX / S&P 12.27% / 10.77% |
LoseCPIX / S&P CPIX unavailable / -15.69% |
| 2022-Q41/3 |
LoseCPIX / S&P -6.64% / 7.56% |
WinCPIX / S&P 16.75% / 11.88% |
LoseCPIX / S&P CPIX unavailable / -17.99% |
| 2022-Q31/3 |
WinCPIX / S&P 15.87% / -4.88% |
LoseCPIX / S&P 10.85% / 13.47% |
LoseCPIX / S&P CPIX unavailable / -1.41% |
| 2022-Q20/3 |
LoseCPIX / S&P -26.24% / -16.10% |
LoseCPIX / S&P -1.54% / 13.71% |
LoseCPIX / S&P CPIX unavailable / 11.04% |
| 2022-Q10/3 |
LoseCPIX / S&P -39.61% / -4.60% |
LoseCPIX / S&P -6.21% / 15.97% |
LoseCPIX / S&P CPIX unavailable / 42.23% |
| 2021-Q41/3 |
WinCPIX / S&P 74.25% / 11.03% |
LoseCPIX / S&P -3.89% / 15.00% |
LoseCPIX / S&P CPIX unavailable / 96.40% |
| 2021-Q30/3 |
LoseCPIX / S&P -5.96% / 0.58% |
LoseCPIX / S&P 5.28% / 10.77% |
LoseCPIX / S&P CPIX unavailable / 69.42% |
| 2021-Q21/3 |
LoseCPIX / S&P -5.94% / 8.55% |
WinCPIX / S&P 16.51% / 6.58% |
LoseCPIX / S&P CPIX unavailable / 51.81% |
| 2021-Q11/3 |
LoseCPIX / S&P 2.71% / 6.17% |
WinCPIX / S&P 18.86% / -1.06% |
LoseCPIX / S&P CPIX unavailable / 7.39% |
| 2020-Q41/3 |
LoseCPIX / S&P -8.10% / 12.15% |
WinCPIX / S&P 8.88% / -3.72% |
LoseCPIX / S&P CPIX unavailable / -33.42% |
| 2020-Q31/3 |
LoseCPIX / S&P -3.60% / 8.93% |
WinCPIX / S&P 29.51% / -2.04% |
LoseCPIX / S&P CPIX unavailable / -27.10% |
| 2020-Q21/3 |
LoseCPIX / S&P -8.26% / 20.54% |
WinCPIX / S&P 14.15% / -0.46% |
LoseCPIX / S&P CPIX unavailable / -27.11% |
| 2020-Q11/3 |
LoseCPIX / S&P -29.51% / -19.60% |
WinCPIX / S&P 10.58% / 3.47% |
LoseCPIX / S&P CPIX unavailable / -14.75% |
| 2019-Q41/3 |
LoseCPIX / S&P -13.15% / 9.07% |
WinCPIX / S&P 17.19% / 5.36% |
LoseCPIX / S&P CPIX unavailable / 2.99% |
| 2019-Q30/3 |
LoseCPIX / S&P -6.91% / 1.70% |
LoseCPIX / S&P -30.11% / 5.02% |
LoseCPIX / S&P CPIX unavailable / 0.21% |
| 2019-Q21/3 |
WinCPIX / S&P 9.64% / 4.30% |
LoseCPIX / S&P -30.92% / 6.64% |
LoseCPIX / S&P CPIX unavailable / 8.65% |
| 2019-Q10/3 |
LoseCPIX / S&P -3.65% / 13.65% |
LoseCPIX / S&P CPIX unavailable / 8.12% |
LoseCPIX / S&P CPIX unavailable / 14.29% |
| 2018-Q41/3 |
WinCPIX / S&P 5.60% / -13.52% |
LoseCPIX / S&P -28.69% / 9.05% |
LoseCPIX / S&P CPIX unavailable / 18.23% |
| 2018-Q30/3 |
LoseCPIX / S&P -6.85% / 7.71% |
LoseCPIX / S&P CPIX unavailable / 10.21% |
LoseCPIX / S&P CPIX unavailable / 19.06% |
| 2018-Q20/3 |
LoseCPIX / S&P -8.23% / 3.43% |
LoseCPIX / S&P CPIX unavailable / 9.03% |
LoseCPIX / S&P CPIX unavailable / 14.46% |
| 2018-Q10/3 |
LoseCPIX / S&P -9.24% / -0.76% |
LoseCPIX / S&P CPIX unavailable / 7.68% |
LoseCPIX / S&P CPIX unavailable / 12.46% |
| 2017-Q41/3 |
LoseCPIX / S&P 4.25% / 6.64% |
WinCPIX / S&P 24.60% / 7.03% |
LoseCPIX / S&P CPIX unavailable / 13.82% |
| 2017-Q30/3 |
LoseCPIX / S&P 0.86% / 4.48% |
LoseCPIX / S&P CPIX unavailable / 5.68% |
LoseCPIX / S&P CPIX unavailable / 17.57% |
| 2017-Q20/3 |
LoseCPIX / S&P 0.86% / 3.09% |
LoseCPIX / S&P CPIX unavailable / 4.83% |
LoseCPIX / S&P CPIX unavailable / 17.74% |
| 2017-Q11/3 |
WinCPIX / S&P 26.18% / 6.07% |
LoseCPIX / S&P CPIX unavailable / 3.67% |
LoseCPIX / S&P -700.00% / 13.32% |
| 2016-Q42/3 |
WinCPIX / S&P 9.78% / 3.82% |
WinCPIX / S&P 3569.51% / 2.09% |
LoseCPIX / S&P -250.00% / 7.05% |
| 2016-Q31/3 |
WinCPIX / S&P 11.33% / 3.85% |
LoseCPIX / S&P CPIX unavailable / 0.20% |
LoseCPIX / S&P -100.00% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | CPIX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 210.61% | 20.78% |
| Annualized return | 210.61% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | CPIX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 276.39% | 83.14% |
| Annualized return | 30.36% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | CPIX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 136.68% | 319.30% |
| Annualized return | 9.00% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |